Stock issues strike again

empty shelves
TGA announces more medicine shortages are now impacting Australia  The Therapeutic Goods Administration (TGA) is advising health professionals and consumers that there is an ongoing shortage of medicines containing olmesartan or prazosin as the sole active ingredient. In order to reduce the impact of these shortages, the TGA has issued Serious Shortage Substitution Notices for

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous Court proceedings over alleged unlawful advertising
Next Battle of the borders